Scribe Therapeutics Inc.
SCTX
IPO
$29.41
-$1.93-6.16%
NASDAQ
| 06/30/2026 | 03/31/2026 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Net Income | -6.48M | -17.35M | -9.90M | ||
| Total Depreciation and Amortization | 785.00K | 773.00K | 836.00K | ||
| Total Amortization of Deferred Charges | -- | -- | 0.00 | ||
| Total Other Non-Cash Items | 1.31M | 7.39M | 862.00K | ||
| Change in Net Operating Assets | -952.00K | 1.63M | 1.57M | ||
| Cash from Operations | -5.34M | -7.56M | -6.63M | ||
| Capital Expenditure | -10.00K | -17.00K | -439.00K | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | 21.93M | 15.57M | 3.10M | ||
| Cash from Investing | 21.92M | 15.55M | 2.66M | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | 145.00K | 93.00K | 51.00K | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -1.52M | -504.00K | 2.00K | ||
| Cash from Financing | -1.38M | -411.00K | 53.00K | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 15.21M | 7.59M | -3.92M | ||